Press Releases
Company Press Releases
For additional media information contact:
Arthur J. Shannon, Vice President, Investor Relations and Communication
ajshannon@perrigo.com
269-686-1709(direct)
269-673-9128 (fax)
Daniel B. Willard, Manager, Investor Relations and Communication
dbwillard@perrigo.com
269-686-1597 (direct)
269-673-9128 (fax)
Archive: 2009 | 2008 |2007 |2006 | 2005 | 2004
2010
Perrigo Confirms Patent Challenge for Clobetasol Propionate Emulsion Foam
July 14, 2010
See Attachment
Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 From Teva
June 29, 2010
See Attachment
Perrigo to Present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging and Leisure Conference
June 25, 2010
See Attachment
Perrigo to Present at the 31st Annual Goldman Sachs Global Healthcare Conference
June 15, 2010
See Attachment
Perrigo Announces FDA Final Approval for Miconazole
June 3, 2010
See Attachment
Tentative Approval Received on Generic Version of Halflytely® and Bisacodyl Tablets Bowel Prep Kit
June 2, 2010
See Attachment
Perrigo Acquires Rights to Generic Version of HalfLytely® From Novel Laboratories
May 26, 2010
See Attachment
Perrigo to Present at the Citi Investment Research Global Health Care Conference
May 24, 2010
See Attachment
Perrigo Acquires Exclusive Sales and Distribution Rights to Generic Version of Delsym® From Tris Pharma
May 5, 2010
See Attachment
Perrigo Closes Acquisition of Infant Formula Manufacturer PBM Holdings
May 3, 2010
See Attachment
Perrigo Reports Record Third Quarter Revenue, All-Time Record Earnings, and Raises Full Year Adjusted EPS Guidance
April 29, 2010
See Attachment
Perrigo Announces Quarterly Dividend
April 28, 2010
See Attachment
Perrigo will Release Third Quarter Fiscal 2010 Results on April 29, 2010
April 16, 2010
See Attachment
Perrigo is Named Authorized Generic Partner by Ferndale Laboratories and Launches Analpram HC® Cream
April 15, 2010
See Attachment
Perrigo and Graceway Settle Litigation and Name Perrigo as Authorized Generic Distributor for Aldara®
April 13, 2010
See Attachment
Perrigo Wins Unfair Competition Case
April 8, 2010
See Attachment
Perrigo and Partner Cobrek Announce Settlement of Luxiq® Patent Litigation
April 5, 2010
See Attachment
Perrigo and Partner Cobrek Launch Generic Version of Evoclin® and Announce Settlement of Related Litigation
April 5, 2010
See Attachment
Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
March 23, 2010
See Attachment
Perrigo Announces Launch of Generic Version of Zaditor™
March 15, 2010
See Attachment
Perrigo Acquires Australia's Leading OTC Store Brand Supplier
March 1, 2010
See Attachment
Perrigo Announces FDA Final Approval for Ciclopirox Shampoo
February 18, 2010
See Attachment
Perrigo Granted Summary Judgment of Non Infringement in Mucinex® Case
February 12, 2010
See Attachment
Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
February 2, 2010
See Attachment
Perrigo Announces Quarterly Dividend
January 27, 2010
See Attachment
Perrigo Will Release Second Quarter Fiscal Year 2010 Results on February 2, 2010
January 19, 2010
See Attachment
Perrigo to Present at the 28th Annual J.P. Morgan Healthcare Conference
January 7, 2010
See Attachment
We have provided our Press Releases in Adobe® Portable Document Format.
1. To view a Press Release, you need to have

o Click here to go to the Adobe site to download the Adobe® Acrobat software.
o When the download is complete, you will need to install the software on your computer.
2. If your computer already has the Adobe® Acrobat Reader, or you have completed the steps above, click on the Press Release you want to read.